News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Arm shares slid after HSBC cut its rating to Hold.
  • HSBC said Arm's rapid AI-driven rally has outpaced fundamentals.
  • HSBC raised its price target to $315, implying roughly 5% upside from the July 13 close.
  • HSBC flagged near-term AI server CPU shipment constraints from limited TSMC 3nm capacity.
  • TSMC's notable 3nm capacity additions aren't expected until the second half of 2027.
  • The downgrade and capacity limits increase pressure on Arm and other AI hardware valuations.

Latest Articles

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Parabilis Medicines, a clinical-stage biopharmaceutical company developing novel medicines targeting historically undruggable proteins, closed its upsized initial public offering on Nasdaq under ticker PBLS at $20 per share. The IPO raised gross proceeds of $770.5 million, including full exercise of underwriters' over-allotment option. Additionally…

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

Kyntra Bio announced new data from the Phase 3 MATTERHORN trial showing the drug roxadustat significantly improves transfusion independence in patients with anemia due to lower-risk myelodysplastic syndromes (LR-MDS), regardless of ring sideroblast (RS) status. The company is finalizing the protocol for a pivotal Phase 3 trial based on FDA feedback…

CTW to Participate and Present at Planet MicroCap Las Vegas 2026

CTW to Participate and Present at Planet MicroCap Las Vegas 2026

CTW, a leading game platform company specializing in anime IP-based free-to-play web games, announced that CFO Patrick Liu will participate and present at the Planet MicroCap Las Vegas 2026 investment conference from June 16-18. The presentation and one-on-one meetings aim to engage investors and showcase CTW's business and growth strategies.

Raise Equity Now: Agentic AI & Asset Exposure Make Alphabet a Buy

Raise Equity Now: Agentic AI & Asset Exposure Make Alphabet a Buy

Alphabet is uniquely positioned to monetize the next wave of agentic AI while providing diversified upside through stakes in SpaceX and Anthropic. Fundamentals remain solid (market cap ~$4.34T, EPS $13.14, FCF $64.4B), valuation is reasonable for a compounder, and the current technical pullback offers a tactical entry. Actionable trade plan include…

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

Nanox Imaging Ltd announces it will release its first quarter 2026 financial results on June 25, 2026, followed by a conference call hosted by CEO Erez Meltzer and CFO Ran Daniel. The company provides an update on its integrated medical imaging platform aimed at expanding preventive healthcare through affordable imaging technology, AI analytics, cl…

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

Ascendis Pharma announced positive five-year Phase 2 data from the PaTH Forward Trial demonstrating that TransCon PTH (palopegteriparatide) provides sustained multi-organ benefits, normalizes calcium levels, improves kidney function and quality of life, and allows independence from conventional therapies in adults with hypoparathyroidism. High pati…

Citi Lowers Super Retail Earnings and Price Target Citing Higher Costs

Citi Lowers Super Retail Earnings and Price Target Citing Higher Costs

Citi reduced its fiscal 2027 earnings estimate for Super Retail Group by 5% and cut its price target to A$14.20 after the company updated guidance to reflect higher corporate and project costs. Super Retail is planning to grow its store footprint from 790 to more than 900 locations by 2031, while Citi highlighted longer-term potential in brands suc…

SpaceX’s $75 Billion IPO Sets Stage for a New Wave of Mega Listings

SpaceX’s $75 Billion IPO Sets Stage for a New Wave of Mega Listings

On June 11, SpaceX completed a $75 billion initial public offering, the largest on record, surpassing the previous high set by Saudi Aramco in 2019. The rocket and satellite manufacturer is scheduled to begin trading on the Nasdaq on Friday. Market attention has shifted to potential follow-on mega listings, notably from AI companies OpenAI and Anth…

SpaceX’s path to a record-breaking IPO

SpaceX’s path to a record-breaking IPO

SpaceX completed a historic U.S. initial public offering in June 2026, raising $75 billion after a public pricing at $135 per share. The company’s ascent to that landmark financing followed more than two decades of development, operational milestones, rocket failures and recoveries, government contracts, commercial service rollouts and strategic mo…

Trump Says Strait of Hormuz Will Reopen After Looming Iran Settlement

Trump Says Strait of Hormuz Will Reopen After Looming Iran Settlement

President Donald Trump told reporters the Strait of Hormuz will be reopened once a "great settlement" with Iran is signed, an outcome he said could come within days. He described the deal as ending Iran's pursuit of a nuclear weapon, called off planned strikes earlier in the day and said he had spoken with regional leaders about the agreement. Tehr…

SpaceX Sets IPO Price at $135; Nasdaq Listing Scheduled for June 12, 2026

SpaceX Sets IPO Price at $135; Nasdaq Listing Scheduled for June 12, 2026

Space Exploration Technologies Corp. priced its initial public offering at $135 per share, covering 555,555,555 Class A common shares, with trading expected to begin on June 12, 2026, on the Nasdaq Global Select Market and Nasdaq Texas under the ticker SPCX. The base sale would generate roughly $75 billion, and an underwriter over-allotment option …